Europe Sarcopenia Treatment Market
No. of Pages: 78 | Report Code: BMIRE00030430 | Category: Life Sciences
No. of Pages: 78 | Report Code: BMIRE00030430 | Category: Life Sciences
The Europe sarcopenia treatment market was valued at US$ 993.46 million in 2022 and is expected to reach US$ 1,467.81 million by 2030; it is estimated to register a CAGR of 5.0% from 2022 to 2030. Rise in Malnutrition and Vitamin Deficiency Among Adults Boosts Europe Sarcopenia Treatment Market
Malnutrition is one of the major risk factors for sarcopenia. According to the WHO, approximately 2.3 billion adults worldwide were undernourished as of 2021, representing nearly 30% of the global population. Among the reported risk factors, protein-energy deficiency is a frequent cause of sarcopenia. Further, vitamin D deficiency or insufficiency is positively associated with an increased risk of multiple illnesses, such as cancer, obesity, cardiovascular disease, and sarcopenia. According to the National Institutes of Health (NIH), nearly 50% of the world's population suffers from vitamin D insufficiency, and ~1 billion people are vitamin D deficient.Europe Sarcopenia Treatment Market Overview
The sarcopenia treatment market in Europe is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Europe occupies a significant position in the global sarcopenia treatment market and is estimated to register a notable CAGR during the forecast period.
Germany is an attractive market due to its innovative approach toward healthcare. According to the Federal Statistical Office, health expenditure in this country amounted to US$ 474 billion in 2021. The awareness of sarcopenia and sarcopenic obesity (SO) is gradually increasing in aging societies across Germany. Sarcopenia and SO are comparatively uncommon (<5%) among German men aged 70 and above. Therefore, an upsurge in the cases of orthopedic disorders, coupled with the rising demand for nutritional supplements, drives the growth of the sarcopenia treatment market in Germany.
Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
Strategic insights for the Europe Sarcopenia Treatment provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market. The geographic scope of the Europe Sarcopenia Treatment refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
Get more information on this report Europe Sarcopenia Treatment Strategic Insights
Get more information on this report Europe Sarcopenia Treatment Report Scope
Report Attribute
Details
Market size in 2022
US$ 993.46 Million
Market Size by 2030
US$ 1,467.81 Million
Global CAGR (2022 - 2030)
5.0%
Historical Data
2020-2021
Forecast period
2023-2030
Segments Covered
By Treatment Type
By Distribution Channel
Regions and Countries Covered
Europe
Market leaders and key company profiles
Get more information on this report Europe Sarcopenia Treatment Regional Insights
Get more information on this report
Europe Segmentation
The Europe sarcopenia treatment market is categorized into treatment type, distribution channel, and country.
Based on treatment type, the Europe is segmented into vitamin D and calcium supplement, protein supplement, vitamin B12 supplement, and others. The vitamin D and calcium supplement segment held the largest Europe share in 2022.
In terms of distribution channel, the Europe is segmented into pharmacies, retail channels, online channels, and others. The pharmacies segment held the largest Europe share in 2022.
By country, the Europe is segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. Germany dominated the Europe share in 2022.
Abbott Laboratories, Amway Corp, Bayer AG, GSK Plc, Metagenics LLC, Nestle Health Science SA, Novartis AG, Pfizer Inc, and Sanofi SA are some of the leading companies operating in the Europe .
1. Abbott Laboratories
2. Amway Corp
3. Bayer AG
4. GSK Plc
5. Metagenics LLC
6. Nestle Health Science SA
7. Novartis AG
8. Pfizer Inc
9. Sanofi SA
The Europe Sarcopenia Treatment Market is valued at US$ 993.46 Million in 2022, it is projected to reach US$ 1,467.81 Million by 2030.
As per our report Europe Sarcopenia Treatment Market, the market size is valued at US$ 993.46 Million in 2022, projecting it to reach US$ 1,467.81 Million by 2030. This translates to a CAGR of approximately 5.0% during the forecast period.
The Europe Sarcopenia Treatment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Sarcopenia Treatment Market report:
The Europe Sarcopenia Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Sarcopenia Treatment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Sarcopenia Treatment Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Sarcopenia Treatment Market
